England - London • Corporate and commercial
Covington & Burling LLP
We only have limited information for this firm. Consider the following firms which have provided more information:
Known for its industry-specific expertise across the life sciences, technology, energy and financial services sectors, Covington & Burling LLP‘s capital markets practice group draws on extensive US securities knowledge to advise across the full spectrum of cross-border ECM transactions. Corporate practice vice-chair Gregor Frizzell leads the team, which also includes Simon Amies, a highly experienced partner with more than 25 years in the ECM space.
Legal 500 Editorial commentary
Key clients
- Allergy Therapeutics PLC
- Arecor Therapeutics PLC
Abbreviated data is displayed for this firm.
Work highlights
- Advised AIM-listed Destiny Pharma PLC in two equity fundraises to raise approximately £14.45 million in the aggregate.
- Advised Peel Hunt LLP, as Nomad and Joint Bookrunner, and finnCap Ltd, as Joint Bookrunner, in a follow-on financing by Shield Therapeutics plc to raise up to £19 million.
Abbreviated data is displayed for this firm.